Background illustration for clinical trials search

Paid Clinical Trials Bradenton

Discover 1,425 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Tampa FL, Coral Springs FL, Tamarac FL, Atlanta GA,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659782

Phase 2, Recruiting

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Tampa FL, Gainesville FL, Savannah GA, Bluffton SC,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06616584

Phase 2, Phase 3, Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

for
Migraine
Location: Tampa FL, Fort Myers FL, Orlando FL, Winter Park FL,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05125302

Phase 3, Recruiting

IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Tampa FL, Madison WI
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06940440

Phase 1, Recruiting

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for
Prostate Cancer (Adenocarcinoma),
Location: Tampa FL, Myrtle Beach SC, Baltimore MD, Boston MA,
Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male

Age: 18+

Code: NCT06801236

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Tampa FL, Miami FL, Jacksonville FL, Greenville NC,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase 2, Phase 3, Recruiting

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Leukemia, Myeloid, Acute, Myelodysplastic Syndromes,
Location: Tampa FL, Nashville TN, New York NY, Hackensack NJ,
Sponsor: Orca Biosystems, Inc.

Sex: All

Age: 18+

Code: NCT07216443

Phase 2, Recruiting

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

for
Pyoderma Gangrenosum
Location: Tampa FL, Miami FL, New Orleans LA, Birmingham AL,
Sponsor: LEO Pharma

Sex: All

Age: 18+

Code: NCT06624670

Phase 3, Recruiting

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: Tampa FL, Newnan GA, Myrtle Beach SC, Nashville TN,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07213674

Phase 3, Recruiting

Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs

for
Skin Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07222995

Recruiting

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

for
Acute Myeloid Leukemia (AML)
Location: Tampa FL, Miami FL, Chapel Hill NC, Durham NC,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07007312

Phase 3, Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

for
Ovarian Neoplasms, Breast Neoplasms,
Location: Tampa FL, Durham NC, Indianapolis IN, Glen Burnie MD,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213791

Phase 1, Recruiting

Clinical Pre-screening Protocol for Ovarian Cancer

for
Ovarian Cancer
Location: Tampa FL, Atlanta GA, Oklahoma City OK, New York NY,
Sponsor: Allarity Therapeutics

Sex: Female

Age: 18+

Code: NCT03877796

Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

for
Advanced Solid Tumor, Advanced Malignant Neoplasm,
Location: Port Charlotte FL, Orlando FL, Miami FL, Durham NC,
Sponsor: PMV Pharmaceuticals, Inc

Sex: All

Age: 12+

Code: NCT04585750

Phase 1, Phase 2, Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

for
Bladder Cancer, Recurrent Bladder Cancer,
Location: Tampa FL, Chapel Hill NC, Nashville TN, Columbus OH,
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07225127

Recruiting

The MIND-BC Study: MIND Diet for Breast Cancer Cognition

for
Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: Female

Age: 18+

Code: NCT07018986

Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

for
NSCLC Stage IV
Location: Tampa FL, Fort Myers FL, Fort Lauderdale FL, Miami FL,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS

for
Relapsed Acute Myeloid Leukemia (AML),
Location: Tampa FL, Chapel Hill NC, Nashville TN, Houston TX,
Sponsor: Auron Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06846606

Phase 1, Recruiting

A First-in-Human Study of FID-022 in Solid Tumor Patients

for
Pancreatic Cancer, Cancer Cachexia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT07249775

Recruiting

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

for
Cervical Cancer
Location: Tampa FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT07216703

Phase 3, Recruiting